Clinical Trials in Tennessee

Showing 13941-13960 of 17,345 trials

Study of Erbitux™ (Cetuximab) in Pediatric Patients With Refractory Solid Tumors

NCT00110357

The purpose of this clinical research study is to establish the maximum tolerated dose and recommended Phase II dose of Erbitux™ in combination with Irinotecan in pediatric and adolescent patients with refractory solid tumors.

CancerRefractory Solid Tumor

Eli Lilly and Company48 participantsStarted Aug 2005

Phoenix, Arizona, United States • Tucson, Arizona, United States • Denver, Colorado, United States +6 more locations

COMPLETEDNA29 miles

A Test of Different Degrees of Cost Sharing on Program Uptake and Attendance

NCT01756066

To test the uptake of four different cost sharing discounts for enrolling in the Weight Watchers weight loss program as well as outcomes (program attendance and weight loss) over 12 months.

Obesity

University of Pennsylvania1,239 participantsStarted Jan 2013

Davidson, North Carolina, United States • Nashville, Tennessee, United States

TERMINATEDPhase 129 miles

Bradykinin Receptor Blocker in ACE Inhibitor-associated Angioedema

NCT00517582

Individuals with heart disease or high blood pressure are often prescribed angiotensin converting enzyme (ACE) inhibitors to treat their disease. However, the use of ACE inhibitors can be associated with angioedema, a rare but life-threatening condition that causes swelling of the face and other body parts. This study will evaluate the effectiveness of the drug HOE-140 at decreasing symptoms of angioedema in people taking ACE inhibitors who develop the condition.

Angioneurotic Edema

Vanderbilt University13 participantsStarted Sep 2007

Nashville, Tennessee, United States

Study of Erbitux™ (Cetuximab) in Pediatric Patients With Refractory Solid Tumors

A Test of Different Degrees of Cost Sharing on Program Uptake and Attendance

Bradykinin Receptor Blocker in ACE Inhibitor-associated Angioedema

Find Trials by Condition in Tennessee

Study of Taxane/Carboplatin +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer

Study to Evaluate the Effect of Cetuximab on Corrected QT (QTc) Interval Changes in Patients With Advanced Malignancies From Solid Tumors

Study of Menactra® in Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of Age

Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer

A Safety and Efficacy Study of ELND002 in Patients With Relapsing Forms of Multiple Sclerosis

An Extension Study Investigating the Efficacy and Safety of a Fast-Dissolving ("Melt") Formulation of Desmopressin for the Treatment of Nocturia in Adults

Study of Ombrabulin in Patients With Platinum-Sensitive Recurrent Ovarian Cancer Treated With Carboplatin/Paclitaxel

Comparison of Safety and Efficacy of Tizanidine Hydrochloride Capsules Versus Zanaflex® (Tizanidine Hydrochloride Tablets) Taken While in the Fed State (Just After a Meal) and in the Fasted State (Before a Meal) in Patients With Moderate to Severe Spasticity.

BNC105P Combination Study in Partially Platinum Sensitive Ovarian Cancer Patients

Vitamin D3 Treatment in Pediatric Systemic Lupus Erythematosus

Evaluation of MST-188 in Acute Lower Limb Ischemia

Safety and Dose Study of GRN163L to Treat Patients With Chronic Lymphoproliferative Disease(CLD)

A Study of AVE8062 in Advanced-stage Soft Tissue Sarcoma After Failure of Anthracycline and Ifosfamide Chemotherapies

99th Percentile Upper Reference Limit (URL) for the Meritas Troponin I Test

Cognitive Behavior Therapy and Habit Reversal Training for the Treatment of Chronic Tic Disorders in Children

Study in Genotype 2 or 3 Patients With Chronic Hepatitis Virus Infection

Study of GRN163L With Paclitaxel and Carboplatin in Patients With Advanced or Metastatic Non Small Cell Lung Cancer